Olema Pharmaceuticals, Inc.OLMANASDAQ
Loading
R&D Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+24.2%
5Y CAGR+63.0%
Year-over-Year Change
Research and development spending
3Y CAGR
+24.2%/yr
vs +164.0%/yr prior
5Y CAGR
+63.0%/yr
Recent deceleration
Acceleration
-139.8pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
11.5x
Strong expansion
Streak
7 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $157.70M | +26.6% |
| 2024 | $124.52M | +44.6% |
| 2023 | $86.14M | +4.7% |
| 2022 | $82.27M | +61.0% |
| 2021 | $51.10M | +272.9% |
| 2020 | $13.70M | +249.6% |
| 2019 | $3.92M | +131.5% |
| 2018 | $1.69M | - |